CNTX | Context Therapeutics Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.2000 - 2.3257
52 Week Range	0.7700 - 2.7500
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	83,978
Average Volume	242,778
Shares Outstanding	74,998,300
Market Cap	167,246,209
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-10-20

Valuation
Profitability
Growth
Health
P/E Ratio	-2.32
Forward P/E Ratio	N/A
EPS	-0.96
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	5
Country	USA
Website	CNTX

Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also developing CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for gynaecologic cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

CNTX's peers: TERN, AMLX, ABOS, INZY, XFOR, SPRO, BOLT, CHRS, GRCL, NLTX, DAWN, VECT, NXTC, CTMX, ASMB, ZURA, ANNX, ICVX, INAB, WVE, XRTX

*Chart delayed

Analyzing fundamentals for CNTX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see CNTX Fundamentals page.

Watching at CNTX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on CNTX Technicals page.